GLP-1 Hair Loss in 2026: Why Month 4 Is the Shower-Drain Moment, and What Actually Helps

Fourteen weeks into Wegovy, you notice the drain. Not a horror-movie clump, just a small dark mat that wasn't there in February. A hand through wet hair on the way to the towel pulls another dozen strands. The pillowcase has six or seven the next morning. By Friday you're counting, and the count is north of 150 a day.

Nothing else changed. Same shampoo, same stress, same job. The pen in the fridge has been working: down 22 lb since February. Reddit confirms what your group chat already suspects, and the trial data confirms Reddit. Month 3 to month 5 on a GLP-1 is the shower-drain moment for a meaningful share of users. You are not allergic to semaglutide, and you are almost certainly not going bald.

What you are seeing is telogen effluvium, a dermatology phenomenon that predates Ozempic by a hundred years. The drug isn't poisoning your follicles. The rate of weight loss is. The lag between trigger and visible shed runs 2 to 4 months, which is why month 4 is the canonical complaint window. There is a small set of things that actually help, a longer set that doesn't, and a short list of red flags that mean the shed is something else.

Here is the version of that conversation a careful dermatologist would have with you, calibrated to the molecule on your prescription as of April 2026.

What the trials actually said about hair loss

Three pivotal trials carry the cleanest numbers, and they tell one story. The faster the weight loss, the higher the alopecia adverse-event rate. The drug-class effect is real but secondary to the rate-of-loss effect.

Tirzepatide at 15 mg roughly doubles the alopecia signal of semaglutide at 2.4 mg, and the average weight loss runs roughly 6 percentage points higher. Liraglutide, where average weight loss runs around 8%, sits at the placebo baseline in SCALE Obesity. The molecule matters less than the slope of the curve.

Foundayo is the new variable. Lilly's oral GLP-1 (orforglipron) cleared the FDA on April 1, 2026, list price $149 per month. ATTAIN-1 registered an alopecia signal in the safety data, with the precise rate still being characterized as the registry matures. The mechanism is identical to the injectables. Rapid weight loss drives the shed regardless of the route of administration.

A 5.7% number sounds alarming next to 1.0% placebo. Restated: one in 17 patients on top-dose tirzepatide reported a noticeable shed across 72 weeks of trial follow-up. Real, common enough to plan for, almost always temporary.

The biology — telogen effluvium, not the drug

Your scalp carries 100,000 to 150,000 follicles, each cycling on its own clock through three phases. Anagen is active growth, 2 to 6 years long. Catagen is a 2 to 3 week regression. Telogen is the resting phase that lasts roughly 3 months and ends when a new anagen hair pushes the resting strand out. In steady state, 85 to 90% of follicles sit in anagen and 10 to 15% in telogen. Daily shed in healthy adults runs 50 to 100 strands. You shed every day. You just don't notice when the cohort is staggered.

Telogen effluvium is what happens when the cohort isn't staggered anymore. A stressor pushes a wave of follicles out of anagen and into telogen at the same time. The follicles don't die. They synchronize their resting phase. The shed surfaces 2 to 4 months later because that's how long telogen lasts. The strands you see in the drain in week 14 left anagen back in week 4 to week 8.

Dermatologists and obstetricians have catalogued the classical TE triggers for decades: childbirth, high fever, surgery under general anesthesia, severe psychological stress, crash diets, iron and protein and zinc and B12 deficits, thyroid swings in either direction, and stopping estrogen-containing oral contraceptives. GLP-1 weight loss drops cleanly into the rapid-weight-loss bucket.

The arithmetic matters. STEP 1 averaged 14.9% body-weight loss over 68 weeks. SURMOUNT-1 averaged 20.9% on tirzepatide 15 mg over 72 weeks. For a 90 kg starting weight that's 13 to 19 kg, often concentrated in the first 6 months while titration is still climbing. The caloric deficit, the protein gap that comes with suppressed appetite, and the metabolic shift push a synchronized cohort of follicles into telogen. Three to five months later, the cohort sheds.

Three features distinguish this shed from the alopecias you should worry about more.

• Diffuse, not patchy. Density drops across the whole scalp at once. No coin-sized bald spots.
• Non-scarring. Pull a shed strand and the bulb is club-shaped, white, intact. The follicle is dormant, not destroyed.
• Self-limited. The active wave runs 3 to 6 months from the trigger. Full density typically returns 6 to 12 months after the trigger stops, though regrowth feels slow because new hairs come in short and gradually catch up to existing length.

Who is at the highest risk

Some patients sail through six months on Zepbound without losing a single extra strand. Others hit month 4 and can't leave the bathroom without sweeping the floor. The risk isn't random.

The biggest predictor is the slope. Patients who escalate from 0.25 mg to 1.0 mg semaglutide on the standard 16-week ladder, then push to 1.7 mg at week 16 and 2.4 mg at week 20, lose weight faster than patients who stretch each step by an extra 4 weeks. Loss above roughly 1.5% of body weight per week is the rate that strongly predicts TE in the obesity-medicine literature. At 100 kg starting weight, that's 1.5 kg a week. If you're hitting that, you are at the threshold.

Protein intake is the second lever. Hair is keratin, keratin is protein, and below 0.8 g/kg of actual body weight per day the TE risk roughly doubles. The dermatology consensus target for hair-loss-prone patients is 1.2 to 1.6 g/kg of actual body weight per day, weighted toward leucine-rich sources like whey, eggs, fish, and lean meat. A 75 kg adult needs 90 to 120 g per day. On a drug suppressing appetite, hitting that number takes deliberate planning.

Then there's ferritin, the storage form of iron. Dermatology wants greater than 50 ng/mL for hair regrowth, which is meaningfully higher than the CBC "normal" range that bottoms out around 15 to 30. Premenopausal women, vegetarians and vegans, and anyone who lost weight rapidly twice in the past five years are the highest-risk groups. A standard CBC will not flag you. Ask for a ferritin level by name.

Two more risk profiles worth flagging. Perimenopause shortens anagen as estrogen drops in the late 40s and early 50s, so the baseline shed creeps up before Wegovy enters the picture; stack a GLP-1 on top and the shed is heavier and longer than it would be at 30. And if you've shed hard before — postpartum, post-surgery, after a brutal year at work — your follicles have a documented willingness to synchronize under stress, and a GLP-1 will likely produce the same pattern.

A bonus risk worth flagging on its own: a family history of pattern hair loss. Androgenetic alopecia is the slow, miniaturization-based hair loss most adults associate with "going bald." It is a separate condition from TE. A GLP-1-driven TE episode can unmask underlying AGA in patients trending that way already, by accelerating the timeline of visible thinning. The shed itself is still TE. The slower thinning that follows is the AGA that was always coming, surfacing 5 to 10 years earlier than it might have otherwise.

What helps, what doesn't, and what makes it worse

The hierarchy is unglamorous and specific.

Slow titration is the intervention with the largest effect size and the lowest cost. If you're at week 16, hitting your weekly weight-loss number, and watching density drop, ask your prescriber for an extra 4 weeks at the current dose before the next escalation. Total time to maintenance dose stretches by a month. Total weight-loss outcome at 72 weeks is generally unchanged. The TE trigger softens.

Protein is the macronutrient most under-eaten on GLP-1s, because GLP-1s suppress appetite for protein-heavy meals as effectively as they suppress appetite for everything else. Two practical anchors: a scoop of whey in your morning coffee or smoothie buys 25 g without volume, and a small can of tuna or a 100 g grilled chicken breast at lunch buys another 25 to 30 g. Build out from there. If solid food is unmanageable on a titration week, two scoops of whey in 200 mL of milk delivers 50 g of protein in something you can sip.

Ferritin is the lab to push for. The standard CBC will say "iron is fine" with a ferritin of 18 ng/mL, because the CBC reference range bottoms out around 15. Hair regrowth wants more than 50. Request the level by name. Below 50, oral iron (ferrous sulfate or ferrous bisglycinate) typically moves ferritin up about 30 ng/mL across 12 to 16 weeks, faster with vitamin C alongside, slower with calcium or coffee.

Topical minoxidil 5% has the strongest evidence base in the regrowth phase, but the labeling is precise. Minoxidil extends anagen and accelerates the transition of resting follicles back into growth. It will not stop a shedding wave already underway. Expect a brief shedding spike in the first 4 to 8 weeks of starting it, as resting follicles synchronize their re-entry into anagen. Push through. The spike is the drug working. The women's foam version has been OTC in the US since 2014; the men's 5% solution since 1997. Both are widely available without a prescription.

Biotin is the supplement most patients reach for first and the supplement with the weakest evidence outside true deficiency, which is rare. Most "hair vitamins" sold online are biotin plus zinc plus a handful of B vitamins. Taking them is unlikely to hurt and unlikely to do much. One caveat worth knowing: high-dose biotin (over 5000 mcg per day) interferes with the assay used for many thyroid panels and for cardiac troponin tests. If your doctor is monitoring your thyroid, or you end up in an ER with chest pain, biotin can produce false readings. Stop it 72 hours before any draw, and disclose any current use to the lab.

A few habits make the shed look worse without causing it: aggressive bleaching and color processing, daily heat styling above 350°F, tight ponytails and braids that traction-pull at the crown, and harsh sulfate-heavy shampoos used daily. None of these cause TE. All of them accelerate the perception of thinning by breaking fragile, finer regrowth strands before they can mature.

Minoxidil works for regrowth, not for stopping the active shed. Biotin gummies do almost nothing. Protein and ferritin are unsexy and they are the two interventions with real numbers behind them. If you do nothing else, fix protein at 1.2 to 1.6 g/kg and push ferritin above 50.

When to escalate to a dermatologist

TE is benign and self-limited. The five scenarios below are not TE, and the fix is not on the supplement aisle.

• Patchy bald spots, especially smooth coin-sized circles. Suggests alopecia areata, an autoimmune condition that needs different treatment.
• Scalp pain, redness, scaling, or visible inflammation. Scarring alopecias destroy the follicle permanently and are time-sensitive. A dermatology appointment in the next 2 weeks, not the next 6 months.
• Shedding more than 300 strands per day for more than 2 months, or any shedding pattern continuing past 12 months from the original trigger. TE should be resolving by then.
• Hair that breaks mid-shaft easily, especially when you tug a strand gently. Mid-shaft breakage suggests protein deficiency severe enough that the strand itself is structurally weak, or chemical damage layered on top of TE.
• A family history of pattern hair loss with rapid acceleration during the GLP-1 phase. The TE may be unmasking AGA. Topical minoxidil plus, for some patients, oral finasteride or low-dose oral minoxidil are the AGA-specific tools your dermatologist can prescribe.

A dermatology visit also helps when the shed is causing real psychological distress, regardless of medical urgency. Hair density is part of how many adults perceive their identity, and the shower-drain moment can be more upsetting than a textbook implies. A trichoscopy in the office takes 5 minutes, confirms the diagnosis, and frequently reduces the anxiety more than any pill in the cabinet.

How this looks across the major GLP-1 markets

Same molecules, same TE physiology, slightly different brand names and pharmacy channels. The alopecia AE rates carry across geographies because the trial set is the same.

In the US, Foundayo (orforglipron) joined the lineup on April 1, 2026 at a $149 per month list price. The ATTAIN-1 alopecia signal is in the safety data, and the 2026 to 2027 label updates should give a specific percentage as the registry matures.

In Korea, the average prescribing visit at a 비만 클리닉 runs short, and the hair-loss conversation often doesn't happen unless the patient initiates it. If you're on Wegovy or Mounjaro and you hit month 3, raise protein and ferritin at the next refill. The pharmacy will not bring it up.

Japan splits sharply by channel. PMDA-registered endocrinology and obesity clinics handle side-effect counseling seriously. Cosmetic-import clinics often don't. If your semaglutide source is a Tokyo or Osaka cosmetic clinic, expect a lower counseling baseline and plan accordingly.

In China mainland, 诺和盈 (Wegovy) launched in 2025 with the standard semaglutide safety profile printed in Chinese on the box. Hospital pharmacy is the safest channel for follow-up labs and dermatology referral. Community pharmacy varies in how thoroughly the shedding question gets handled at refill.

Taiwan approved 猛健樂 (Mounjaro) for obesity in September 2024, and 善纖達 (Saxenda) remains widely prescribed. TFDA-aligned dermatology referrals are well-supported in the public hospital system. The cosmetic-clinic channel in Taipei, as in Tokyo, is the variability segment.

Questions to bring to your prescriber at the next visit

Fifteen minutes with a prescriber is enough to change the conversation, if you walk in with the right questions.

1. "Given my current weight-loss rate, am I above or below the 1.5% per week threshold that predicts telogen effluvium?" Ask for the math. If the answer is above, ask whether holding the current dose for an extra 4 weeks before the next escalation is appropriate.
2. "Can you order a ferritin level, vitamin D, B12, and TSH at the next blood draw?" Ferritin is the one most often missed. Push for the number, not "your iron is fine."
3. "What is my current protein intake, and am I hitting 1.2 to 1.6 g/kg of my actual body weight?" Bring a 3-day food log if you can. Most patients on a GLP-1 underestimate by 30 to 40 g per day.
4. "Do you want me on topical minoxidil 5%, and if so, the women's foam or the 5% solution?" The OTC versions don't require a prescription, but the prescriber's input on timing — start at month 3 versus wait for visible thinning — is worth getting.
5. "If the shed lasts more than 6 months, or if I notice patches or scalp pain, what is your dermatology referral pathway?" Get the name and the timeline now, not in month 9 when the shed is still going.
6. "Is anything in my family history pointing toward androgenetic alopecia layered under the TE?" If yes, the conversation about oral finasteride or oral minoxidil shifts onto the table.

Before you fill or refill in the next 7 days

A short, practical checklist for any GLP-1 patient at month 0 to month 6.

• Confirm your starting weight and your current weekly weight-loss rate. If you're above 1.5% per week, plan a slow-titration conversation at the next visit.
• Build your protein floor before appetite drops further. 1.2 to 1.6 g/kg of actual body weight per day, leucine-rich, spread across 3 to 4 meals. A scoop of whey in the morning is the easiest 25 g you'll hit all day.
• Request a ferritin level, vitamin D 25-OH, B12, and TSH at your next blood draw. Aim for ferritin >50, vitamin D ≥30, B12 ≥400. Recheck in 12 to 16 weeks if you supplement.
• If you're starting OTC topical minoxidil 5%, expect a brief shedding spike in weeks 4 to 8. The spike is the drug working. Don't quit on day 30.
• Stop high-dose biotin (over 5000 mcg) at least 72 hours before any thyroid panel or troponin test. Disclose any biotin use to the lab on the day of the draw.
• Skip the bleaches, the daily 400°F flat iron, and the high-tension ponytails for the duration of the active shed. Sulfate-free shampoos are easier on fragile regrowth.
• Photograph your part line and your hairline under the same bathroom light every 4 weeks. The eye doesn't register slow regrowth. The phone does.

For context on how GLP-1 access and dosing decisions are evolving across markets in 2026, our piece on who qualifies for GLP-1 in 2026 covers eligibility criteria. For the molecule that joined the class in April with the newest safety profile, the Foundayo orforglipron guide walks through the oral GLP-1 in depth. And for women weighing pregnancy plans during the same hair-loss window, the GLP-1 and pregnancy 2026 guide covers washout windows and contraception interactions that often surface in the same month-3 to month-6 timeframe.

The shower-drain moment is alarming. It is also the most common, the most reversible, and the most fixable side effect of meaningful GLP-1 weight loss. Most patients see full density back by month 12 to month 18 from the original trigger. Bring the protein question and the ferritin question to your next refill, before the next escalation, while the math is still on your side.

Start managing your GLP-1 with Blueshot

AI coaching, injection scheduling, and weight tracking in one app